OTTAWA, June 9, 2003 ( – Health Canada has given initial approval to allowing provision of the abortifacient morning after pill over-the-counter according to the National Post.  The report says the government will solicit public feedback before finalizing any changes to the drug’s status.  In March last year, Paladin Labs Inc., the Montreal company that distributes the abortifacient morning after pill, Plan B, announced it had submitted an application to Health Canada to change Plan B, from prescription-only to non-prescription status. In their release, Paladin noted that the Canadian Pharmacists Association and the Society of Obstetricians and Gynecologists of Canada collaborated on the submission.  Campaign Life Coalition (CLC) urged Health Canada to reject the move explaining that the morning after pill “acts upon the uterine lining to make it hostile to the implantation of the human embryo. This would be analogous to leaving a newborn baby alone in the desert and is clearly an abortifacient action.”  See related LifeSite coverage:  COMPANY ASKS HEALTH CANADA TO ALLOW OVER-THE-COUNTER MORNING AFTER PILL   (with files from National Post June 4, 2003)